SOLESENCE INC
SLSNNASDAQTrading Snapshot
- Day Range
- $894.09 β $908.01
- 52-Week Range
- $0.61 β $4.55
- Volume
- $2.87B
- Avg Volume
- $3.67B
- Shares Outstanding
- 70.6M
- Next Earnings
- Oct 31, 2026
Fundamentals Snapshot
- Annual Revenue
- $62M
- Last Q Revenue
- $15M
- P/E Ratio
- β
- P/S Ratio
- 1.1x
- EPS (TTM)
- $-0.03
- Dividend Yield
- β
- Dilution (1yr)
- +4.0%
Why Investors Own SLSN
- βHigh-growth profile β revenue up +47.2% YoY with expanding US Equity exposure.
- βHealthy economics β 55% gross margin and 6% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
SOLESENCE INC
SLSNAbout SOLESENCE INC
Solesence, Inc., formerly known as Nanophase Technologies Corporation, specializes in the development and production of clean-label, inclusive, and mineral-based skincare and cosmetic products. The company collaborates with a diverse range of partners, from major global corporations to independent brands, employing its unique Active Stress Defenseβ’ technology suite. Through this proprietary system, Solesence brings innovative beauty solutions to the market that provide effective environmental protection.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
SOLESENCE INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift SLSN price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
SOLESENCE INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.